Lockdown E-CME & Webinars - this one is on Pfizer vaccine - Prevenar,
We have also discussed the common questions on Pneumonia & how to run clinical practice during COVID shutdown
Choosing a pneumococcal vaccine - wisely.. Prevenar in Indian contextGaurav Gupta
Choosing a pneumococcal vaccine - wisely.. Prevenar in Indian context latest studies as of July 2018,
Which vaccine is the best in India as of 2018, latest studies and scientific data
At the four front of flu vaccination - Quadrivalent Flu Vaccination in India ...Gaurav Gupta
Is flu vaccination needed in India? Is there any benefits of Quadrivalent Flu vaccination over Trivalent Flu vaccination? Any safety & efficacy data about Vaxiflu 4 by Zydus Vaccines. All discussed in a Presentation in Panchkula, in September 2019
Top 10 practical questions about Flu Vaccine in India!Gaurav Gupta
What does a practising paediatrician want to to know about the Flu vaccination? Talk for Abbott Vaccines (Influvac Tetra) in Oct 2020 about common queries that doctors have about the flu vaccine in India, including how it may help in COVID-19?
Hep a Live & Inactivated vaccines in IndiaGaurav Gupta
dIAP presentation for GSK - Havrix and comparison of Live and inactivated Hepatitis A vaccines in Dec 2020.. Online discussion about the various Hep A vaccines available and their pros and cons
Choosing a pneumococcal vaccine - wisely.. Prevenar in Indian contextGaurav Gupta
Choosing a pneumococcal vaccine - wisely.. Prevenar in Indian context latest studies as of July 2018,
Which vaccine is the best in India as of 2018, latest studies and scientific data
At the four front of flu vaccination - Quadrivalent Flu Vaccination in India ...Gaurav Gupta
Is flu vaccination needed in India? Is there any benefits of Quadrivalent Flu vaccination over Trivalent Flu vaccination? Any safety & efficacy data about Vaxiflu 4 by Zydus Vaccines. All discussed in a Presentation in Panchkula, in September 2019
Top 10 practical questions about Flu Vaccine in India!Gaurav Gupta
What does a practising paediatrician want to to know about the Flu vaccination? Talk for Abbott Vaccines (Influvac Tetra) in Oct 2020 about common queries that doctors have about the flu vaccine in India, including how it may help in COVID-19?
Hep a Live & Inactivated vaccines in IndiaGaurav Gupta
dIAP presentation for GSK - Havrix and comparison of Live and inactivated Hepatitis A vaccines in Dec 2020.. Online discussion about the various Hep A vaccines available and their pros and cons
Influenza vaccine is nothing new . However there are lesser known facts about Influenza vaccine. This is just a humble attempt to highlight a few important points about Influenza vaccine, including some updates.
Burden of Influenza disease worldwide.
Importance of Influenza vaccine in Corona virus pandemic.
Influenza vaccine quadrivalent vs trivalent vaccine.
Split virion vs Subunit influenza vaccine
0.5 ml dose of influenza vaccine below 3 yrs age in children
Northern hemisphere or Southern hemisphere influenza vaccine for India, some suggestions
Prevention of influenza in relation to COVID 19 - the TWINDEMICGaurav Gupta
What is the concern about the TWINDEMIC of COVID 19 & Influenza?
My talk on the digital IAP platform in Dec 2020 for the pediatricians across the country
ROTAVIRUS VACCINES IN INDIA .WHICH ONE WILL YOU CHOOSE AND WHY?DR SHAILESH MEHTA
Many brands of Rotavirus vaccine are available in India. However we need to have full evidence based decision making before we choose one rotavirus vaccine over another. This slideshow focuses on the need to have Indian studies which are not there with some of the international brands. Regionwise variability of rotavirus vaccines have prompted ICMR and various other scientific bodies in India to have our own data on efficacy of rotaviral vaccines in Indian scenario. Diarrhoea is a major cause of under 5 mortality in children. After the use of rotavirus vaccines there is a huge reduction of financial burden on our healthcare sytems.
Childhood diarrhoea incidence and severity have decreased ever since rotavirus vaccine was made a part of national immunization schedule.
Hepatitis A is an under rated infectious disease in children , with high morbidity and a major cause of fulminant hepatitis in children.There has been a longstanding debate between the LIVE VACCINE FOR HEPATITIS A AND THE KILLED INACTIVATED VACCINE FOR HEPATITIS A. Recent CDC guidelines and INDIAN ACADEMY OF PEDIATRICS GUIDELINES and recent references were studied before making these slides. Hope you find these useful.
Prospects for GBS prevention - current candidates & removing barriers to licensure of a GBS vaccine for pregnant women globally
https://www.meningitis.org/mrf-conference-2017
As in the past, MPCA will again present an immunization update on influenza vaccines. Both Seasonal Flu vaccine and H1N1 flu vaccine will be included in this presentation.
Emerging concepts in pneumococcal disease prevention in India sept 2011Gaurav Gupta
Latest information about Pneumococcal disease and its prevention from Indian perspective - as of sept 2011.
Covers latest Pneumonet data, and review from other studies like IBIS, ANSORP etc.
Flu Vaccination Dr Sharda Jain
Contents
What is Influenza
Influenza outbreaks and pandemics
Impact of Influenza
Influenza vaccine: Rationale
Influenza vaccine safety & effectiveness
When, whom & how to vaccinate?
Adult Vaccination in an ageing society: Immune responseILC- UK
Highlights the importance of vaccinating older people in the context of an ageing society. Sets out how levels of uptake vary across Europe. And highlights ideas for policy makers on how to increase uptake of adult vaccination
What next for prevention of pneumococcal disease in light of serotype replacement? Is there a pathway to licensure for novel pneumococcal vaccines?
https://www.meningitis.org/mrf-conference-2017
Influenza vaccine is nothing new . However there are lesser known facts about Influenza vaccine. This is just a humble attempt to highlight a few important points about Influenza vaccine, including some updates.
Burden of Influenza disease worldwide.
Importance of Influenza vaccine in Corona virus pandemic.
Influenza vaccine quadrivalent vs trivalent vaccine.
Split virion vs Subunit influenza vaccine
0.5 ml dose of influenza vaccine below 3 yrs age in children
Northern hemisphere or Southern hemisphere influenza vaccine for India, some suggestions
Prevention of influenza in relation to COVID 19 - the TWINDEMICGaurav Gupta
What is the concern about the TWINDEMIC of COVID 19 & Influenza?
My talk on the digital IAP platform in Dec 2020 for the pediatricians across the country
ROTAVIRUS VACCINES IN INDIA .WHICH ONE WILL YOU CHOOSE AND WHY?DR SHAILESH MEHTA
Many brands of Rotavirus vaccine are available in India. However we need to have full evidence based decision making before we choose one rotavirus vaccine over another. This slideshow focuses on the need to have Indian studies which are not there with some of the international brands. Regionwise variability of rotavirus vaccines have prompted ICMR and various other scientific bodies in India to have our own data on efficacy of rotaviral vaccines in Indian scenario. Diarrhoea is a major cause of under 5 mortality in children. After the use of rotavirus vaccines there is a huge reduction of financial burden on our healthcare sytems.
Childhood diarrhoea incidence and severity have decreased ever since rotavirus vaccine was made a part of national immunization schedule.
Hepatitis A is an under rated infectious disease in children , with high morbidity and a major cause of fulminant hepatitis in children.There has been a longstanding debate between the LIVE VACCINE FOR HEPATITIS A AND THE KILLED INACTIVATED VACCINE FOR HEPATITIS A. Recent CDC guidelines and INDIAN ACADEMY OF PEDIATRICS GUIDELINES and recent references were studied before making these slides. Hope you find these useful.
Prospects for GBS prevention - current candidates & removing barriers to licensure of a GBS vaccine for pregnant women globally
https://www.meningitis.org/mrf-conference-2017
As in the past, MPCA will again present an immunization update on influenza vaccines. Both Seasonal Flu vaccine and H1N1 flu vaccine will be included in this presentation.
Emerging concepts in pneumococcal disease prevention in India sept 2011Gaurav Gupta
Latest information about Pneumococcal disease and its prevention from Indian perspective - as of sept 2011.
Covers latest Pneumonet data, and review from other studies like IBIS, ANSORP etc.
Flu Vaccination Dr Sharda Jain
Contents
What is Influenza
Influenza outbreaks and pandemics
Impact of Influenza
Influenza vaccine: Rationale
Influenza vaccine safety & effectiveness
When, whom & how to vaccinate?
Adult Vaccination in an ageing society: Immune responseILC- UK
Highlights the importance of vaccinating older people in the context of an ageing society. Sets out how levels of uptake vary across Europe. And highlights ideas for policy makers on how to increase uptake of adult vaccination
What next for prevention of pneumococcal disease in light of serotype replacement? Is there a pathway to licensure for novel pneumococcal vaccines?
https://www.meningitis.org/mrf-conference-2017
NEWER VIRAL VACCINE ICLUDED RECENT ADVACES IN THE VACCINE DEVELOPMENT And as per WHO 2023 data pipeline vaccine detail like HIV, TB, DENGUE, HPV,FLU VACCINE AND ALSO EMPHASIS ON THE COVID VACCINE AND AS PER LATEST 2023 GOEVENMENT OF INDIA AND WORLD HEALTH ORGANISATION
Dr Marie-Pierre Preziosi's presentation at Meningitis Research Foundation's 2013 conference, Meningitis & Septicaemia in Children & Adults http://www.meningitis.org/conference2013
Efforts made in many countries to stop the COVID-19 pandemic include vaccinations. However,
public skepticism about vaccines is a pressing issue for health authorities. With the COVID-19 vaccine
available,
Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
Current Status and Future Perspective of Rapid Diagnostic Kits Vaccine agains...ijtsrd
Coronavirus disease 2019 COVID 19 , which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China. The etiological agent of COVID 19 has been confirmed as a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 SARS CoV 2 , which is most likely originated from zoonotic coronaviruses, like SARS CoV, which emerged in 2002. Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus 2019 nCoV outbreak. Currently, various diagnostic kits to test for COVID 19 are available and several repurposing therapeutics for COVID 19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID 19. Here, we review the current status of, diagnosis, and vaccine development for COVID 19. M A Nandedkar | R A Shinde | S S Bansode "Current Status and Future Perspective of Rapid Diagnostic Kits / Vaccine against COVID-19" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30977.pdf Paper Url :https://www.ijtsrd.com/pharmacy/analytical-chemistry/30977/current-status-and-future-perspective-of-rapid-diagnostic-kits--vaccine-against-covid19/m-a-nandedkar
Breastfeeding in Women with Covid19 infection-Expert group meeting for develo...Niranjan Chavan
Breastfeeding in Women with Covid19 infection-Expert group meeting for development of standard treatment protocols for clinical management of covid- 19 complicating pregnancy at New Delhi 8th December 2021
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
Expanded Program of Immunization.
Objectives are:
To learn about EPI and the current situation of EPI in Pakistan
To understand the mechanism of the Cold Chain and the maintenance of vaccines
Version 10th August 2021.
Addendum to Ministry of Health, Malaysia's Guidelines Version 2, Dated 23rd June 2021 For the full list of updates, please visit https://cutt.ly/c19vak
Designing vaccines for specific populations and germs - Slides by Professor E...WAidid
The presentation given by Professor Susanna Esposito at ECCMID 2019. A view on vaccines recommendations, combined vaccinations and impact of vaccination practices in the eradication of major infectious diseases.
To learn more, please visit www.waidid.org
Similar to Prevenar e cme june 2020 & FAQs & COVID Clinic Questions (20)
Impact of Social Media on Mental Health.pptxGaurav Gupta
## Social Media: The Ups and Downs for Young Minds
**Uncover the impact of social media on children's mental health.**
This presentation explores the complex relationship between social media and the developing minds of children. We'll delve into:
* **The positive connections:** How social media fosters friendships, self-expression, and access to information.
* **The potential pitfalls:** Increased anxiety, depression, body image issues, and cyberbullying.
* **Strategies for healthy use:** Explore practical tips for parents and educators to promote safe and balanced social media habits in children.
**Equip yourself with the knowledge to guide young people in navigating the social media landscape.**
Good evening everyone, and thank you for joining me today. Today we’ll be exploring the impact of social media on the mental health of children and adolescents. Social media is an undeniable part of our lives, and pediatricians are in a unique position to guide parents and children in navigating this digital landscape.
How AI will transform Pediatric Practice - Feb 2024Gaurav Gupta
Creating a concise and compelling summary for a SlideShare presentation on "How AI Will Transform Pediatric Practice" involves highlighting key points that emphasize AI's potential benefits, challenges, and future implications in pediatric healthcare. Here's a structured summary that could be effectively used in your SlideShare:
---
**Title: Transforming Pediatric Practice: The Role of AI**
**Introduction:**
- Briefly introduce the current state of pediatric practice, emphasizing the importance of accurate diagnosis, personalized treatment, and efficient healthcare delivery.
- Introduce Artificial Intelligence (AI) as a transformative tool in medicine, with a focus on pediatrics.
**AI's Impact on Diagnostics:**
- Highlight how AI algorithms enhance diagnostic accuracy in pediatric care, enabling early detection of diseases through pattern recognition in imaging, genomics, and clinical data.
- Discuss case studies where AI has successfully identified pediatric conditions earlier and more accurately than traditional methods.
**Personalized Treatment Plans:**
- Explain how AI contributes to the development of personalized medicine in pediatrics, considering the unique genetic, environmental, and lifestyle factors of each child.
- Provide examples of AI systems recommending customized treatment protocols and monitoring disease progression in real-time.
**Operational Efficiency and Patient Care:**
- Illustrate AI's role in streamlining administrative tasks, scheduling, and patient flow, allowing healthcare professionals to focus more on patient care.
- Discuss AI-powered virtual health assistants and chatbots that provide 24/7 support and guidance to caregivers, answering questions and offering advice based on medical guidelines.
**Challenges and Ethical Considerations:**
- Address the challenges of integrating AI into pediatric practice, including data privacy, ethical considerations, and the need for robust training data.
- Discuss the importance of balancing AI tools with human oversight to ensure compassionate and empathetic patient care.
**The Future of AI in Pediatrics:**
- Envision a future where AI not only supports clinical decision-making but also predicts health outcomes, identifies potential public health crises, and contributes to global pediatric health research.
- Highlight the importance of interdisciplinary collaboration in developing AI tools that are ethical, equitable, and truly beneficial for child health.
**Conclusion:**
- Summarize the transformative potential of AI in pediatric practice, emphasizing its role in enhancing healthcare delivery, improving patient outcomes, and paving the way for innovative treatment approaches.
- Call to action for healthcare professionals, researchers, and technologists to collaborate in harnessing the power of AI for the betterment of pediatric healthcare.
Latest GINA guidelines for Asthma & COVIDGaurav Gupta
What are the changes from 2019 onwards till 2022, in the GINA guidelines for developing countries like India.
Includes COVID guidelines and also a FUN QUIZ !
Talk about why these guidelines have changed - use of ICS - formoterol combination for treating even intermittent asthma
Dr Naveen Kini, Pediatrician from Bengaluru talks about WHAT is podcasting, HOW we can listen to podcasts, WHY doctors should create podcasts and much more. Co-hosted with Dr Gaurav Gupta. In arrangement with dIAP and CMIC. This is PART 1 - we discuss how to create a simple free & easy podcast in part 2 - check the presentation on slideshare under my account
Podcast creation for doctors (Pediatricians)Gaurav Gupta
What are podcasts, why should doctors listen to podcasts, how can doctors create a podcast. With Dr Naveen Kini - as a part of CMIC initiative, this program was broadcast on dIAP network on 15th July 2021, This is part 2 of the presentation by me. I talk about HOW to create a podcast easily and for free using the Anchor.fm app
Helping doctors avoid COVID in their Office PracticeGaurav Gupta
Tips for doctors and their patients to avoid Coronavirus during OPD practice in India. From a Pediatrician's perspective. How can we take supplements prophylactic medicines like Vit D, Vit C, Zinc, etc. and medicines like HCQ or Ivermectin to prevent COVID during seeing patients in our practice.
Digital eye strain - Computer vision syndrome for students during Online clas...Gaurav Gupta
Dr. Poonam Gupta, Eye Specialist from Charak Clinics, Mohali, talks with Aakash Institute about Computer vision syndrome, Digital Vision Syndrome, Eye fatigue in students doing online classes during the lockdown. How to prevent it and treat with with simple steps including the 20-20-20 rule etc.
Digital waste management pedicon 2020 Indore, preconference workshopGaurav Gupta
What is important and relevant about Digital waste management pedicon 2020 Indore, preconference workshop. How to dispose of your printers, computers, mobile phones, relevant to India
How to Advertise yourself with simple office tools PEDICON 2020 Indore workshop 8 jan, 2020. How to use whatsapp, blogs, youtube facebook to advertise yourself online
Zyvac TCV - The Indian Typhoid Conjugate VaccineGaurav Gupta
Presented at Ambala in Jan 2020. Is TCV needed, and is it better than Polysaccharide vaccine. Indian data and studies by Dr. Gaurav Gupta, Pediatrician from Charak Clinics, Mohali
Dr. Gaurav Gupta - Should you be buying an E-bike this Diwali?
Dr RP Bansal- Feeding difficulties in the newborn
Dr Nivedita- Tips on how to Continue Breast Feeding
Dr Ridhi- Teething tips
Dr Arushi - First afebrile seizure
Dr Amit - Mesentric lymphadenopathy
Dr Gunjan - Acute events following immunization plus update on BCG adenitis
Dr Sandip Jain- Tips for examining children
Dr Diljot - Mefenemic acid as an antipyretic
Dr Jaskaran- colicky infant : knowledge , attitude and practices
Dr Shailesh - School se chutti kitne din karayein ?
Dr Gaurav- Is it oral Herpes? Visual Quiz
Meningococcal disease sep 2019 National Epidemiology & Indian recommendationsGaurav Gupta
IAP tricity Panel Discussion on Need for Meningococcal Vaccination, Panel discussion featuring Professors from PGIMER Chandigarh Pediatrics Dept, Microbiology Department
Japanese encephalitis - Sep 2019 India epidemiology - Is vaccination needed?Gaurav Gupta
IAP Chandigarh Meeting presentation on a Panel Discussion on the need for JE vaccination in Indian situation, especially for private practitioners in and around Chandigarh, North India
Research in pediatrician office - my story! NORC Aug 2019 New DelhiGaurav Gupta
Presented in NORC - Aug 2019 - National Original Research convention, discussion of Flu like illnesses and the Flu vaccination and drug utilization reviews and prescription audits and various other original research presented and published by Dr. Gaurav Gupta in his years of clinical practice, including yellow fever, Complementary medicines, drug costs and prescriptions analysis
What nelson forgot 4 - Super CME for Common Pediatric OPD questionsGaurav Gupta
What nelson forgot 4 - Super CME for Common Pediatric OPD questions, 12th July 2019
Common Office practice questions, answered in just 5-10 minutes per topic ...
A group of Pediatricians from Chandigarh discussing common OPD problems in office practice.
5 minutes per topic for the speaker ONLY, discussing 15-20 topics every time !
Rotavirus vaccine - Rotateq- Does Valency Matter North Zone Pedicon oct 2018Gaurav Gupta
Rotavirus vaccine - Rotateq- Does Valency Matter North Zone Pedicon oct 2018 - talk taken in the holy city of amritsar as a part of the First NZ pedicon for IAP. Discussed the differences and benefits of Rotavirus vaccines that are available in India including Rotateq, Rotarix, Rotavac Rotasure and Rotasiil
Dr. Bhavesh Shah, Pediatrician and member CMIC, IAP, from Vadodara talks about best app for pediatricians at IAP Chandigarh Meeting.- discusses free & paid apps and also best apps as per budget of the doctor
Dr. Bhavesh Shah, Member CMIC, Vadodara, presents tips for Mobile phone maintenance for Doctors,
Also discusses dataplans for smartphones & broadband connections.
IAP Quarterly meet, Chandigarh
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prevenar e cme june 2020 & FAQs & COVID Clinic Questions
1. Managing Immunization in
the challenging times
How should one address the situation?
Dr. Gaurav Gupta,
Charak Clinics, Mohali
2.
3. Scope
ACVIP guidelines for immunization during COVID
Pneumonia Vaccines – PCV 10 & 13 in India
Pneumonia Vaccines – above 5 years age
Your FAQs about vaccines
Your OPINIONS about vaccination during COVID
4. ACVIP Guidelines on Immunizations during COVID 19
Pandemic
• Prevention (including immunizations) and management of communicable diseases is considered as
an “Essential Medical service”
• Immunization should be prioritized for the prevention of communicable diseases and safeguarded
for continuity during the COVID-19 pandemic, where feasible
• There is no documented risk of immunizing a well child during the COVID 19 Pandemic.
1. ACVIP Guidelines on Immunizations during COVID 19 Pandemic. Iapindia.org. 2020 [cited 20 May 2020]. Available from: https://iapindia.org/pdf/1455-FINAL-ADVISORY-ACVIP-Guidelines-on-Immunisations-
during-COVID-19-Pandemic-skd.pdf
COVID-19: coronavirus disease 2019
ACVIP: Advisory Committee On Vaccines & Immunization Practices
PP-PNP-IND-0382 29 May 2020
5. General instructions for vaccination clinics
1. Have exclusive vaccination
sessions and exclusive
vaccination rooms.
2. Segregate those with fever
and respiratory symptoms
3. Give vaccinations by
appointment only
4. Digital Payment.
5. Stagger appointments & allow
1-2 attendants, discourage
dada-dadi
6. Do SMS –yourself & pts.
7. Aggressive infection control
8. Adequate PPE, surgical mask
and gloves with scrupulous hand
hygiene.
9. Utilize every healthcare visit
including well baby visits for
immunization.
1. ACVIP Guidelines on Immunizations during COVID 19 Pandemic. Iapindia.org. 2020 [cited 20 May 2020]. Available from: https://iapindia.org/pdf/1455-FINAL-ADVISORY-ACVIP-Guidelines-on-Immunisations-
during-COVID-19-Pandemic-skd.pdf PP-PNP-IND-0382 29 May 2020
6. How to Prioritize vaccines?
• Give first year vaccines on time
• Give multiple vaccines at the same time
• Boosters may be delayed if logistic issues
• Catch-up vaccines whenever child comes to the clinic, or when
conditions favourable
7. Prioritizing Vaccines in routine immunization
1. Vaccinate newborns at birth
before discharge. BCG^,
OPV & Hep-B vaccines.
2. Prioritize primary vaccination
series: DPT, Hep B, Hib,
OPV/IPV, RV vaccines,
PCV, Influenza, Varicella
and MR/MMR..
3. Prioritize pneumococcal and
Influenza vaccine to
vulnerable groups incl HCW.
4. JE at 1 year
5. TCV with influenza vaccine at 6
months or MR/MMR at 9
months.
6. HAV & HPV may be postponed
to a later date if needed.
7. Multiple vaccines in the same
session.
1. ACVIP Guidelines on Immunizations during COVID 19 Pandemic. Iapindia.org. 2020 [cited 20 May 2020]. Available from: https://iapindia.org/pdf/1455-FINAL-ADVISORY-ACVIP-Guidelines-on-Immunisations-
during-COVID-19-Pandemic-skd.pdf
^BCG: Bacille Calmette-Guerin; OPV: Oral poliovirus vaccine #MR-Measles, Rubella * MMR-
Measles,Mumps,rubella
PP-PNP-IND-0382 29 May 2020
8. Summary of ACVIP guidelines
In view of the risks associated with the disruption of
routine immunization activities, the ACVIP
recommends the continuation of routine
immunizations, especially the primary vaccine doses,
to be administered in the first year
1. ACVIP Guidelines on Immunizations during COVID 19 Pandemic. Iapindia.org. 2020 [cited 20 May 2020]. Available from: https://iapindia.org/pdf/1455-FINAL-ADVISORY-ACVIP-Guidelines-on-Immunisations-
during-COVID-19-Pandemic-skd.pdf
ACVIP: Advisory Committee On Vaccines & Immunization Practices
PP-PNP-IND-0382 29 May 2020
9. Managing Immunization
in the challenging times
Prevention with Pneumococcal Conjugate Vaccines: a
relook in the current scenario
“The Content in this presentation is only intended for healthcare professionals in India. The medical information in this presentation is provided as an
information resource only, and is not to be used or relied on for any diagnostic or treatment purpose. “
“The views and opinions mentioned in the presentation is strictly that of the author and the individuals expressing the same and Pfizer may not necessarily
endorse the same. Pfizer (including its parent, subsidiary and affiliate entities) makes no representation or warranties of any kind, expressed or implied; as
to the content used in the presentation and/or the accuracy, completeness of its content.”
These slides are for information or education purposes only and not for distribution or promotion. PP-PNP-IND-0382 29 May 2020
10. Available Pneumococcal Conjugate Vaccines
DT=diphtheria toxoid; PCV=pneumococcal conjugate vaccine 10-valent [PCV10], or 13-valent [PCV13]); TT=tetanus toxoid; PCV – Pneumococcal Conjugate Vaccine.
1. Vesikari T, et al. Pediatr Infect Dis J. 2009;28(4 suppl):S66-S76;
2. Prevenar 13 Local Product Document LPDPRV062019 version 15.. Pfizer Ltd.;
PCV132
4 6B 9V 14 18C 19F 23F 1 5 7F 3 6A 19A
CRM197
PCV101
4 6B 9V 14 18C 19F 23F 1 5 7F
Protein D TT DT Protein D
PP-PNP-IND-0382 29 May 2020
11. Serotype Coverage Difference Is Present between
PCV10 and PCV13 in Recently Reported Studies
Singh J, Sundaresan S, Manoharan A, Shet A. Serotype distribution and antimicrobial susceptibility pattern in children≤ 5 years with invasive pneumococcal disease in India–A systematic review. Vaccine. 2017
Aug 16;35(35):4501-9.
64.2%
64.0%
68.0%
64.0%
61.0%
64.0%
68.0%
87.5%
74.5%
74.0%
76.0%
92.0%
79.0%
78.0%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
NisargaR
et.al(2015)
BalajiV
et.al(2015)
ManoharanA
et.al(ASIP,
2016)
MehendaleS
et.al(HBSSBM,
2016)
BalasubramanianS
et.al(2016)
ManoharanA
(BASIS,
2016)
VandanaG
et.al(PIDOPS,
2016)
PCV10 PCV13
67.3%
78.4%
60.0%
65.0%
70.0%
75.0%
80.0%
PCV10 PCV13
Proportion(%)ofIPD
11.10%
Difference Attributable to Serotypes 3, 6A and 19A
PCV- Pneumococcal Conjugate Vaccine
PP-PNP-IND-0382 29 May 2020
12. Serotype Coverage Difference between PCV13 and
PCV10 from an Indian Context
Jayaraman Y, Veeraraghavan B, Purushothaman GK, et.al. Burden of bacterial meningitis in India: Preliminary data from a hospital based sentinel surveillance network. PloS one. 2018 May
16;13(5):e0197198.
Pneumococcal Serotypes Covered
by Licensed PCVs
NVS – Non Vaccine Serotypes.
PCV 7
(59%)
PCV 10
(72%)
PCV 13
(90%)
NVS
(10%)
PCV- Pneumococcal Conjugate Vaccine
PP-PNP-IND-0382 29 May 2020
13. *Canadian province of Quebec and Italian region of Piemonte have initiated PCV vaccination programs with PCV10.
†Both PCVs are available/reimbursed in the NIP or the NIP consists of different PCVs by region. BC=birth cohort.
1.Data on file. Pfizer Inc, New York, NY. 2020.
2.Gavi Alliance Annual Progress Report 2017.http://www.gavialliance.org/results/gavi-progress-reports/. Accessed May 16, 2020 [
3. Sachdeva, A., 2017. Pneumococcal conjugate vaccine introduction in India’s Universal immunization program. Indian Pediatrics, 54(6), pp.445-446.
4. Abhipedia.abhimanu.com. 2020. Haryana Launched Pneumococcal Conjugate Vaccine (PCV) And ANMOL App Daily Current Affairs @ Abhipedia Powered By ABHIMANU IAS. [online]
Available at: <https://abhipedia.abhimanu.com/Article/State/MzMzMwEEQQVVEEQQVV/Haryana-launched-Pneumococcal-Conjugate-Vaccine--PCV--and-ANMOL-App-Haryana-State>
[Accessed 29 May 2020].
PCV13 Is Included in Over 125 NIPs, With
Exclusivity in 121 Countries Worldwide1,2
Currently 6 states
have PCV133,4
PCV13 Only* = 121
PCV13 / PCV10† Shared = 6
(PCV13 covers >50% of total BC)
PCV13 / PCV10† Shared = 1
(PCV13 covers <50% of total BC)
PCV10 Only = 31
PP-PNP-IND-0382 29 May 2020
14. Countries Continue to Value the Impact of
PCV13 When Choosing a PCV for Their NIPs
New PCV National Immunization Programs
PCV13
2015 2016 2017 2018 / 2019 2020
PCV10
2015 2016 2017 2018 / 2019 2020
Spain* Mauritius India†
Cambodia Algeria Romania
Portugal Kyrgyzstan
Namibia
Solomon Islands Iraq
Uzbekistan
Eritrea
Lebanon
Poland Serbia
Switched PCV National Immunization Programs
PCV10 to PCV13
2015 2016 2017 2018 / 2019 2020
PCV13 to PCV10
2015 2016 2017 2018 / 2019 2020
Peru Azerbaijan Chile
Belgium
New
Zealand
Armenia Paraguay
Mozambique
El Salvador
Piemonte‡
Myanmar
Haiti
Mongolia
Seychelles
Albania
Quebec ‡
*Launched formal regional immunization programs in 2015.
†Gavi, 5 states only.
‡Canadian province of Quebec and Italian region of Piemonte have initiated PCV vaccination programs with PCV10.
NIP(s)=national immunization program(s).
Data on file. Pfizer Inc, New York, NY. 2020.
Tunisia
Slovenia
Anguilla
Barbados
Bhutan
Trinidad &
Tobago
North Macedonia
(2019)
Croatia
(2019)
Austria
PP-PNP-IND-0382 29 May 2020
15. Is there a place for the use of
PCVs in the pediatric age
group, beyond 5 years?
16. Disease Burden - Indian Scenario
* Include empyema thoracis, deep seated abscess, pericarditis and arthritis;
Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet. 19
99;353(9160):1216‐1221..
Prospective Multicentre Hospital Surveillance of Streptococcus pneumoniae Disease in India
Invasive Bacterial Infection Surveillance (IBIS) Group*, International Clinical Epidemiology Network (INCLEN)
Clinical Syndromes in 314 Patients with Invasive Pneumococcal Infection
Clinical
Syndrome
Age
<2 Months
2 Months –
1.9 Years 2–4.9 Years 5–11.9 Years ≥12 Years Total
Meningitis 2 (67%) 29 (43%) 11 (34%) 15 (28%) 60 (38%) 117 (37.3%)
Pneumonia 1 (33%) 23 (34%) 16 (50%) 13 (25%) 40 (25%) 93 (29.6%)
Septicaemia 0 7 (10%) 1 (3%) 4 (8%) 12 (8%) 24 (7.6%)
Peritonitis 0 0 2 (6%) 11 (21%) 10 (6%) 23 (7.3%)
Others* 0 9 (13%) 2 (6%) 10 (9%) 36 (23%) 57 (18.2%)
Total 3 68 32 53 158 314
There is a disease burden due to Pneumococcal infection, in the pediatric age group,
beyond 5 years as well
PP-PNP-IND-0382 29 May 2020
17. IAP Guidebook on Immunization 2018-19
Healthy Children
• PCV-13 has been licensed for age group of 6–17 years
Shah AK. PNEUMOCOCCAL VACCINES. In: IAP Guidebook on Immunization 2018–2019. 3rd ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2020. p. 168–206.
Other highlights
• Based on surveillance studies, PCV-13 appears to have some edge
over PCV-10 in India.
• On May 13th, 2017, PCV-13 was launched in UIP of selected Indian
states of Himachal Pradesh and parts of Bihar (17 out of 38 districts)
and Uttar Pradesh (6 out of 75 districts). Eventually PCV-13 will be
introduced in all states of India in phased manner in the coming
years.
What’s New?
PP-PNP-IND-0382 29 May 2020
18. Is there a place for the use of PCVs in the
pediatric age group beyond 5 years?
• There is a remaining burden of pneumococcal disease in children >
5 years of age 1
• Clinical studies of PCV13 have demonstrated an immune response
in children ≥5 to 17 years of age comparable to that in children <5
years 2
• IAP guidebook on immunization (2018-19) mentions the use of
PCV13 in children 6–17 years of age3
1. Invasive Bacterial Infection Surveillance (IBIS) Group and International Clinical Epidemiology Network. (INCLEN). Lancet. 1999;353:1216-1221
2. Agarkhedkar S, Juergens C, Balasundaram K, Agarkhedkar S, Sundaraiyer V, Le Dren-Narayanin N, Cutler MW, Gruber WC, Scott DA, Schmoele-Thoma B, B1851140 Study Team. Safety and
Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 6–17 Years of Age in India: An Open-label Trial. The Pediatric infectious disease journal. 2017 Nov 1;36(11):e283-5.
3. Shah AK. PNEUMOCOCCAL VACCINES. In: IAP Guidebook on Immunization 2018–2019. 3rd ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2020. p. 168–206.
4. Prevenar 13 Local Product Document LPDPRV062019 version 15
PP-PNP-IND-0382 29 May 2020
19. Adults need vaccines too1
Vaccines are not just for kids1
1.Centers for Disease Control and Prevention. 2020. Adults Need Vaccines, Too. [online] Available at: <https://www.cdc.gov/features/adultimmunizations/index.html>
[Accessed 27 May 2020].
20. References in the notes section
PCV13 – Adult Vaccine Recommendations in
India
1. Muruganathan A, Mathai D, Sharma SK, editors. Adult Immunization. J Assoc Physicians India; 2014. p. 1-270..
2. Indian Guidelines for Vaccination in Older Adults – A Guide for Geriatricians, Internists, Chest Physicians, Surgeons, Gynaecologists, Diabetologists, Cardiologists, Family Physicians developed by Geriatric Society of India, 2015. Ed. Sharma O.P.
3. Indian Academy of Allergy (2016) Available on http://indianacademyofallergy.com/wp-content/uploads/2017/05/Recommendations-IAACON-2016-Print-version-1.pdf last accessed 18 May 2020
4. Indian Society of Nephrology Guidelines for Vaccination in Chronic Kidney Disease. Indian J Nephrol 2016. Vol 26, Issue 7 (Supplement) Page Nos. 1-30. Available from http://www.indianjnephrol.org/ last accessed on 18 May 2020
5. Mathai, Dilip, et al. "Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims." Journal of Global Infectious Diseases 8.4 (2016): 129.
6. Bajaj S. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017, International journal of diabetes in developing countries:2018;38(1):1-115
7. Indian Medical Association, Life course Immunization guidebook Dec 2018 release at National Annual Conference of IMA (NATCON) held in Bangalore, India in 2018
8. Guidebook on Adult Immunization in Occupational Health Settings Healthy Worker: Key to Productivity and Sustainability. Available at: http://occuconindia.com/img/iaoh_book.pdf Accessed on: 18 May 2020
PP-PNP-IND-0382 29 May 2020
Adapted from reference 1-8
1. Association of Physicians of India1
2. Geriatric Society of India (Indian Vaccine
Advocacy Group)2
3. Indian Academy of Allergy3
4. Indian Society of Nephrology4
5. Mass Gathering Advisory Board Consensus
Recommendation5
6. Research Society for the Study of Diabetes in
India6
7. Indian Medical Association7
8. Indian Association of Occupational Health8
21. PCV 13
6 weeks to 5
years
6 to 17 years > 50 years
The First and Only PCV to Help Protect All Individuals
at Increased Risk for Pneumococcal Disease
Summary – The Heritage
1. Prevenar 13 Local Product Document LPDPRV062019 version 15
2. Pneumococcal conjugate vaccine 10-valent product monograph; August 31, 2018 https://ca.gsk.com/media/591956/synflorix.pdf [Last accessed on 06 January 2020]
PP-PNP-IND-0382 29 May 2020
22. Your PCV questions !
What is the max gap between 2 PCV doses?
How many doses to give in case of missed dose (catch-up schedule)?
If 1 Synflorix given before, what to do if parents want Prevenar now.
Indications and choice of PCV vaccine for vaccinating the kids who were left out on
PCV vaccine earlier in their life.
Rationale and efficacy of govt schedule of pcv vaccine 6, 14 weeks and 9 months.
Evidence behind such schedule and can we do the same to cut the cost to family.
Synflorix and nontypable Hib(NTHi), Don't hear much about the NTHi these days. Any
insights ?
23. Your OPINIONS matter… what are we
doing?
Are we screening for fever before vaccination?
How are we sanitizing our clinics?
What PPE are we wearing?
How are we giving appointments- are we segregating vaccines / non-vaccines/ < 1 year ?
Are we seeing children with fever &/or URI?
Are we physically examining children, including throat and chest?
Are we preferring digital payments? How are we handling cash?
Bathing after clinic, washing clothes separately?
24. Missed something ?
Check www.slideshare.com/gauravg
docgaurav@gmail.com
Parent health education
https://www.youtube.com/charakclinics
Acknowledgements: Dr. Gautam Rambhad, Medical Advisor, Pfizer